5 March 2024
GSK plc (LSE/NYSE: GSK) announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced…
Interim results for the six months ended 31 December 2023 Strong growth in line with expectations and expanded addressable market Dotdigital Group plc (AIM: DOTD), the…
4 March 2024
Hargreaves Services plc (“Hargreaves” or the “Group”) Retirement Benefit Obligation Buy In update Hargreaves Services plc (AIM: HSP), a diversified group delivering services to the…
4 March 2024 TREATT PLC (“Treatt” or “the Group”) Appointment of Chief Executive Officer Treatt, the manufacturer and supplier of a diverse and sustainable portfolio…
4 March 2024 HICL Infrastructure PLC “HICL” or “the Company” and, together with its subsidiaries, “the Group”, the London-listed infrastructure investment company managed by InfraRed…
GlobalData Plc Full Year Results 31 December 2023 Strong results and Adjusted EBITDA margin above 40% for first time Growth Optimisation Plan completed ahead…
AstraZeneca PLC 04 March 2024 4 March 2024 Two datopotamab deruxtecan applications validated in the EU for patients with advanced nonsquamous non-small cell lung…
4 March 2024 Aviva to enter Lloyd’s market via acquisition of Probitas • Entry into Lloyd’s market via acquisition of a high quality, fully-integrated…